From the Journals

Too few Michigan children with SCD receive pneumococcal, meningococcal vaccines

View on the News

Following special vaccine recs for children with SCD essential

This study is particularly valuable because of the “depth, breadth and completeness” of data from across an entire state, a control group that is socioeconomically matched, and a study that was done during a time when new, life-saving vaccines were licensed and recommended. The many changes in the recommendations because of new vaccines and new understanding of the best use of these vaccines make for a complex schedule, but we health care providers need to keep current and to educate parents so their children are protected against infectious diseases. For parents of children with sickle cell disease, the schedule is more complex and the need is greater because of their extreme vulnerability. Wagner et al. suggest that “a proactive electronic prompt to providers [and parents] for vaccines needed for children with special conditions [as exists for the general immunization schedule] is needed – and seems doable.”

Sarah S. Long, MD, is a professor of pediatrics at Drexel University, Philadelphia. She is an associate editor of the Journal of Pediatrics and the Red Book Report of the Committee on Infectious Diseases of the American Academy of Pediatrics. She reported no disclosures. This is a summary of her editorial accompanying the article by Wagner et al. (J. Pediatr. 2018;196:3).


 

FROM THE JOURNAL OF PEDIATRICS


The researchers matched 1,022 children with SCD to 3,725 children without SCD based on age, sex, race, and zip code. The data was based on the Michigan Care Improvement Registry (MCIR), Michigan Vital Records live birth file, and the Michigan Newborn Screening Program for children born in the state between April 1, 1995, and January 1, 2014.

At age 36 months, 69% of children with SCD had been fully vaccinated with the pneumococcal conjugate vaccine series, compared with 45% of children without SCD. The meningococcal vaccine had been administered to 59% of children with SCD.

Children with SCD were more likely than those without the disease to be up-to-date on their pneumococcal vaccine(s) at 5, 7 and 16 months old.

Nevertheless, substantial percentages of children with SCD who received the complete series of the 7-valent pneumococcal conjugate vaccine had not received two other pneumococcal vaccines. Just over 29% were missing a dose of PCV13, 21.8% of children over 2 years old had not received any dose of PPV23, and 50.7% had not received a second dose of PPV23 by the age of 10 years.

Recommended Reading

Early childhood vaccines not associated with increased infection risk
MDedge Pediatrics
Vaccine priming determines teen susceptibility to pertussis
MDedge Pediatrics
Maternal biologic therapy does not affect infant vaccine responses
MDedge Pediatrics
Study links mumps outbreaks to vaccine waning
MDedge Pediatrics
Children with autism, younger siblings are undervaccinated
MDedge Pediatrics
Waning vaccine immunity linked to pertussis resurgence
MDedge Pediatrics
No increased intussusception risk from rotavirus vaccine in Africa
MDedge Pediatrics
Measles exacts high toll among Europe’s youngest citizens
MDedge Pediatrics
MenB vaccine receives breakthrough therapy designation for children aged 1-9 years
MDedge Pediatrics
International travel updates
MDedge Pediatrics